Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Iron ion binding protein" is not a single molecular entity but rather an umbrella term encompassing hundreds of distinct human proteins that bind iron ions. These include well-characterized families such as transferrins (iron transporters in plasma), ferritins (intracellular storage), heme-containing proteins like hemoglobin and myoglobin (oxygen transport/storage), various enzymes requiring non-heme mono-/diiron centers or heme groups for catalysis, and regulatory factors such as iron-responsive element-binding proteins involved in post-transcriptional control of genes related to iron metabolism[1][2][3][4][5][6]. Each subclass has unique structure-function relationships and clinical significance. For example: • Transferrin transports Fe(III) in blood; its receptor mediates cellular uptake. • Ferritin stores up to thousands of Fe atoms per molecule within cells. • Hemoglobin/myoglobin carry oxygen using heme-bound Fe(II). • Many oxidases/dioxygenases use non-heme Fe centers for catalysis. • IRP1/IRP2 regulate translation/stability of mRNAs encoding key metabolic regulators. Because "Iron ion binding protein" refers collectively to these diverse molecules rather than one defined target, it cannot be considered a canonical therapeutic target itself. Instead, individual members—such as "Transferrin receptor," "Ferritin," or "Aconitase"—are valid targets with established roles in health and disease. The term is too broad and unspecific for structured drug discovery or biomarker purposes[1][2][3]. In summary: **"Iron ion binding protein"** is an imprecise label covering many unrelated yet functionally important molecules involved in essential biological processes ranging from oxygen handling to enzymatic catalysis and gene regulation. For structured information relevant to therapeutics or diagnostics, more precise identification at the level of individual family/protein names is required[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Iron ion binding protein.